CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving the diagnosis and management of pancreatic cancer by identifying a gene signature in precursor lesions. It aims to classify patients with intraductal papillary mucinous neoplasms to guide personalized treatment and reduce unnecessary surgeries.
Pancreatic Ductal Adenocarcinoma (PDAC) is a lethal cancer with rising global incidence and poor survival rates.
Early PDAC diagnosis is hampered by non-specific symptoms and by the absence of reliable early biomarkers.
On the other hand, intraductal papillary mucinous neoplasms (IPMNs), precursor lesions of PDAC, are commonly found during abdominal imaging. IPMN management lacks consensus, leading to inefficient decisions decisions on empirical assessments of high-risk stigmata (HRS) and worris…
UNIVERSITA VITA-SALUTE SAN RAFFAELE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, ROMA RM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
